Brock M - Search Results

1

CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target.

Hansel DE, Dhara S, Huang RC, Ashfaq R, Deasel M, Shimada Y, Bernstein HS, Harmon J, Brock M, Forastiere A, Washington MK, Maitra A, Montgomery E. Hansel DE, et al. Among authors: brock m. Am J Surg Pathol. 2005 Mar;29(3):390-9. doi: 10.1097/00000478-200503000-00014. Am J Surg Pathol. 2005. PMID: 15725809

2

Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma.

Brock MV, Gou M, Akiyama Y, Muller A, Wu TT, Montgomery E, Deasel M, Germonpré P, Rubinson L, Heitmiller RF, Yang SC, Forastiere AA, Baylin SB, Herman JG. Brock MV, et al. Clin Cancer Res. 2003 Aug 1;9(8):2912-9. Clin Cancer Res. 2003. PMID: 12912936

3

Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior.

House MG, Guo M, Efron DT, Lillemoe KD, Cameron JL, Syphard JE, Hooker CM, Abraham SC, Montgomery EA, Herman JG, Brock MV. House MG, et al. Among authors: brock mv. J Gastrointest Surg. 2003 Dec;7(8):1004-14; discussion 1014. doi: 10.1016/j.gassur.2003.08.002. J Gastrointest Surg. 2003. PMID: 14675710

4

CD44 loss in gastric stromal tumors as a prognostic marker.

Montgomery E, Abraham SC, Fisher C, Deasel MR, Amr SS, Sheikh SS, House M, Lilliemoe K, Choti M, Brock M, Ephron DT, Zahuruk M, Chadburn A. Montgomery E, et al. Among authors: brock m. Am J Surg Pathol. 2004 Feb;28(2):168-77. doi: 10.1097/00000478-200402000-00003. Am J Surg Pathol. 2004. PMID: 15043305

5

Polypoid esophageal adenocarcinoma--a clinicopathological variant of esophageal cancer?

Brock MV, Are C, Wu TT, Canto M, Yang SC, Heitmiller RF. Brock MV, et al. Curr Surg. 2002 May-Jun;59(3):336-41. doi: 10.1016/s0149-7944(01)00598-0. Curr Surg. 2002. PMID: 16093160

6

Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions.

Montgomery E, Mamelak AJ, Gibson M, Maitra A, Sheikh S, Amr SS, Yang S, Brock M, Forastiere A, Zhang S, Murphy KM, Berg KD. Montgomery E, et al. Among authors: brock m. Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):24-30. doi: 10.1097/01.pai.0000151933.04800.1c. Appl Immunohistochem Mol Morphol. 2006. PMID: 16540726

7

Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer.

Machida EO, Brock MV, Hooker CM, Nakayama J, Ishida A, Amano J, Picchi MA, Belinsky SA, Herman JG, Taniguchi S, Baylin SB. Machida EO, et al. Among authors: brock mv. Cancer Res. 2006 Jun 15;66(12):6210-8. doi: 10.1158/0008-5472.CAN-05-4447. Cancer Res. 2006. PMID: 16778195

8

Hypermethylation of the GATA gene family in esophageal cancer.

Guo M, House MG, Akiyama Y, Qi Y, Capagna D, Harmon J, Baylin SB, Brock MV, Herman JG. Guo M, et al. Among authors: brock mv. Int J Cancer. 2006 Nov 1;119(9):2078-83. doi: 10.1002/ijc.22092. Int J Cancer. 2006. PMID: 16823849

9

Impact of elastic staining on the staging of peripheral lung cancers.

Taube JM, Askin FB, Brock MV, Westra W. Taube JM, et al. Among authors: brock mv. Am J Surg Pathol. 2007 Jun;31(6):953-6. doi: 10.1097/PAS.0b013e31802ca413. Am J Surg Pathol. 2007. PMID: 17527086

10

Epigenetic silencing of CDX2 is a feature of squamous esophageal cancer.

Guo M, House MG, Suzuki H, Ye Y, Brock MV, Lu F, Liu Z, Rustgi AK, Herman JG. Guo M, et al. Among authors: brock mv. Int J Cancer. 2007 Sep 15;121(6):1219-26. doi: 10.1002/ijc.22828. Int J Cancer. 2007. PMID: 17534889

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

856 results

Search Page

Filters